116 related articles for article (PubMed ID: 16162158)
1. Undetectable phospho-STAT1 in peripheral blood mononuclear cells from patients with chronic hepatitis C who do not respond to interferon-alpha therapy.
Aceti A; Zechini B; Griggi T; Marangi M; Pasquazzi C; Quaranta G; Sorice M
Liver Int; 2005 Oct; 25(5):987-93. PubMed ID: 16162158
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients.
Lee CM; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH; Yen YH
J Formos Med Assoc; 2016 Jun; 115(6):440-4. PubMed ID: 26786212
[TBL] [Abstract][Full Text] [Related]
3. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
Liu B; Chen S; Guan Y; Chen L
PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
[TBL] [Abstract][Full Text] [Related]
4. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA-induced innate immune response of human keratinocytes.
Dai X; Sayama K; Yamasaki K; Tohyama M; Shirakata Y; Hanakawa Y; Tokumaru S; Yahata Y; Yang L; Yoshimura A; Hashimoto K
J Invest Dermatol; 2006 Jul; 126(7):1574-81. PubMed ID: 16628196
[TBL] [Abstract][Full Text] [Related]
5. Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.
Miyagi T; Takehara T; Nishio K; Shimizu S; Kohga K; Li W; Tatsumi T; Hiramatsu N; Kanto T; Hayashi N
J Hepatol; 2010 Sep; 53(3):424-30. PubMed ID: 20554341
[TBL] [Abstract][Full Text] [Related]
6. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
[TBL] [Abstract][Full Text] [Related]
7. Expression of interferon alfa signaling components in human alcoholic liver disease.
Nguyen VA; Gao B
Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
[TBL] [Abstract][Full Text] [Related]
8. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
[TBL] [Abstract][Full Text] [Related]
9. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
10. The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy.
El-Saadany S; Ziada DH; El Bassat H; Farrag W; El-Serogy H; Eid M; Abdallah M; Ghazy M; Salem HA
Can J Gastroenterol; 2013 Feb; 27(2):e13-7. PubMed ID: 23472246
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy.
Imanaka K; Tamura S; Fukui K; Ito N; Kiso S; Imai Y; Naka T; Kishimoto T; Kawata S; Shinomura Y;
J Viral Hepat; 2005 Mar; 12(2):130-8. PubMed ID: 15720527
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.
Chen J; Wu M; Zhang X; Zhang W; Zhang Z; Chen L; He J; Zheng Y; Chen C; Wang F; Hu Y; Zhou X; Wang C; Xu Y; Lu M; Yuan Z
Hepatology; 2013 Feb; 57(2):470-82. PubMed ID: 22996189
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.
Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B
J Clin Invest; 2002 Nov; 110(10):1503-13. PubMed ID: 12438448
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C.
Sedeño-Monge V; Santos-López G; Rocha-Gracia RC; Meléndez-Mena D; Ramírez-Mata A; Vallejo-Ruiz V; Reyes-Leyva J
Virol J; 2010 Sep; 7():243. PubMed ID: 20849643
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
[TBL] [Abstract][Full Text] [Related]
16. [SOCS1 knockdown sensitize anti-tumor activity of IFN-alpha2a-NGR].
Huang QC; Lei XY; Liu Y; Sui WJ; Li S; Zhang YQ; Yan Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):412-5. PubMed ID: 20423643
[TBL] [Abstract][Full Text] [Related]
17. Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection.
Wandrer F; Falk CS; John K; Skawran B; Manns MP; Schulze-Osthoff K; Bantel H
J Infect Dis; 2016 Mar; 213(5):746-54. PubMed ID: 26503984
[TBL] [Abstract][Full Text] [Related]
18. PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C.
Gerotto M; Dal Pero F; Bortoletto G; Realdon S; Ferrari A; Boccato S; Alberti A
Antivir Ther; 2004 Oct; 9(5):763-70. PubMed ID: 15535414
[TBL] [Abstract][Full Text] [Related]
19. Decreased interferon-α and interferon-β production in obesity and expression of suppressor of cytokine signaling.
Teran-Cabanillas E; Montalvo-Corral M; Caire-Juvera G; Moya-Camarena SY; Hernández J
Nutrition; 2013 Jan; 29(1):207-12. PubMed ID: 22951153
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling of peripheral-blood mononuclear cells from patients with chronic hepatitis C undergoing interferon therapy.
Tateno M; Honda M; Kawamura T; Honda H; Kaneko S
J Infect Dis; 2007 Jan; 195(2):255-67. PubMed ID: 17191171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
